ro13-9904 and Calcinosis

ro13-9904 has been researched along with Calcinosis* in 2 studies

Reviews

1 review(s) available for ro13-9904 and Calcinosis

ArticleYear
Calcinosis cutis: part II. Treatment options.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:1

    Because calcinosis cutis is a rare syndrome, there is a notable lack of controlled clinical trials on its treatment. The efficacy of calcinosis treatment has only been reported in single cases or small case series. No treatment has been generally accepted as standard therapy, although various treatments have been reported to be beneficial, including warfarin, bisphosphonates, minocycline, ceftriaxone, diltiazem, aluminium hydroxide, probenecid, intralesional corticosteroids, intravenous immunoglobulin, curettage, surgical excision, carbon dioxide laser, and extracorporeal shock wave lithotripsy.

    Topics: Biopsy, Needle; Calcinosis; Ceftriaxone; Combined Modality Therapy; Drug Therapy, Combination; Education, Medical, Continuing; Evidence-Based Medicine; Female; Humans; Immunoglobulins, Intravenous; Immunohistochemistry; Laser Therapy; Lasers, Gas; Male; Minocycline; Prognosis; Recurrence; Risk Assessment; Severity of Illness Index; Skin Diseases; Treatment Outcome; Warfarin

2011

Other Studies

1 other study(ies) available for ro13-9904 and Calcinosis

ArticleYear
Subcutaneous morphea with dystrophic calcification with response to ceftriaxone treatment.
    Journal of the American Academy of Dermatology, 2010, Volume: 63, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Borrelia burgdorferi; Calcinosis; Ceftriaxone; Humans; Male; Panniculitis; Radiography; Scleroderma, Localized; Subcutaneous Tissue

2010